Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Trump threatened "very high" tariffs on Denmark amid Greenland dispute, raising fears of higher prices for Danish pharmaceuticals.

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Imagine reversing a life-altering condition without the use of drugs. One British GP is doing exactly that, and his unconventional methods are turning heads as well as saving lives. Follow his golden ...

As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two main factors: human resources and finance. On one side, there's the potential ...

Americans elect their leaders on the premise that those individuals will be capable of making the right decisions on difficult, as well as easy, issues. An issue on which members of Congress might ...

“Alright, I have a confession to make. Yes, I am on a GLP-1 for a weight-loss medication,” Van Ness said.

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

It is a fair bet to guess that many people taking drugs such as Ozempic are just tired of being fat. The hitch with Ozempic, however, is that is precisely its common purpose.